Early Symptoms of Tuberculosis and Why Prompt Treatment Matters
Tuberculosis (TB) remains one of the world’s most significant infectious threats, claiming approximately 1.25 million lives globally in 2023 alone 3. Despite being a preventable and curable bacterial infection, its ability to remain dormant makes early detection a critical challenge. The primary red flag is a persistent cough lasting three weeks or longer, often accompanied by chest pain and the coughing up of blood or blood-stained sputum 1. These early signs are the body’s alarm system indicating that the Mycobacterium tuberculosis bacteria are actively attacking the lung tissue, necessitating immediate medical evaluation to prevent permanent respiratory damage.
In addition to respiratory issues, the disease often presents with systemic symptoms that are frequently mistaken for minor ailments. Patients may experience unexplained weight loss, a total loss of appetite, and a persistent low-grade fever accompanied by chills 1. One of the most distinctive markers of the infection is the occurrence of heavy night sweats, where a person wakes up with soaked bedding regardless of the room temperature or weather conditions 2. Fatigue and a general sense of weakness also prevail as the body’s immune system is stretched thin while attempting to combat the bacterial load within the lungs.
Prompt treatment is a necessity for both individual survival and public safety because a person with active, untreated pulmonary TB can infect between 10 to 15 other people through close contact in a single year 3. When treatment is delayed, the bacteria have more time to multiply and potentially spread to other parts of the body, such as the spine or kidneys. Furthermore, delaying the start of the standard six-month medication course significantly increases the risk of developing Multi-Drug Resistant TB (MDR-TB). This strain does not respond to the most powerful first-line drugs and requires longer, more toxic, and significantly more expensive treatment regimens with lower survival rates 4.
According to the 2024 WHO Global Tuberculosis Report, while the global treatment success rate for drug-susceptible TB is a high 88%, a massive gap in funding persists. Currently, global investment stands at US$ 5.7 billion, which is far below the required US$ 22 billion annually needed to meet 2027 targets 3. This funding gap limits the availability of rapid diagnostic tools, such as GeneXpert machines, especially in high-burden regions. To mitigate this impact, communities must prioritize environmental ventilation to reduce airborne droplet concentration and ensure strict adherence to the Directly Observed Treatment Short-course (DOTS) strategy, where healthcare workers supervise medication intake 2.
Over the years, CFHI has established strategic partnerships with key stakeholders, particularly the National Tuberculosis and Leprosy Control Programme (NTBLCP), to facilitate community sensitization, mass screenings, and the delivery of essential TB services. Currently, CFHI provides these services in Imo State with support from relevant partners and stakeholders.
Ultimately, ending TB requires early action, community awareness, and the removal of social stigma. If you or anyone you know has experienced a persistent cough for more than two weeks, visit the nearest Primary Health Centre for a free TB test. TB treatment is free at government-supported health facilities, and completing the full course of medication ensures cure and prevents the spread of infection.
By recognizing symptoms early, supporting those undergoing treatment, and encouraging routine screening, we can protect our families and move closer to a TB-free future.
References
- Mayo Clinic: Tuberculosis Symptoms & Causes
- Centers for Disease Control and Prevention (CDC): Basic TB Facts
- World Health Organization (WHO): Global Tuberculosis Report 2024
- Stop TB Partnership: MDR-TB Factsheet
Early Symptoms of Tuberculosis and Why Prompt Treatment Matters Read More »








